BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining ...
A sensor that requires no nanoscale patterning detects single molecules of a breast cancer protein at concentrations 250 ...
A new study combines cfDNA fragmentomes and protein biomarkers to vastly improve early detection of ovarian cancer, offering a cost-effective and robust tool for mass screening. Study: Early detection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback